Hospital infection past and present

por Wilcox, Mark H
Publicado 2003

Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm

por Crowther, Grace S, Wilcox, Mark H
Publicado 2015

A Review of Mixed Strain Clostridium difficile Colonization and Infection

por Dayananda, Pete, Wilcox, Mark H.
Publicado 2019

Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections

por Wilcox, Mark H, Dryden, Matthew
Publicado 2021

Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection

por Baines, Simon D., Wilcox, Mark H.
Publicado 2015

Molecular diagnostic techniques

por Fawley, Warren N, Wilcox, Mark H
Publicado 2005

The predictive value of quantitative nucleic acid amplification detection of Clostridium difficile toxin gene for faecal sample toxin status and patient outcome

por Davies, Kerrie A., Planche, Tim, Wilcox, Mark H.
Publicado 2018

Assessment of potential for viral contamination of user and environment via aerosols generated during hand drying: A pilot study

por Moura, Ines B., Bentley, Karen, Wilcox, Mark H.
Publicado 2022

Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators

por Freeman, Jane, Vernon, Jonathan, Vickers, Richard, Wilcox, Mark H.
Publicado 2015

In Vitro Activities of MCB3681 and Eight Comparators against Clostridium difficile Isolates with Known Ribotypes and Diverse Geographical Spread

por Freeman, Jane, Pilling, Sally, Vernon, Jonathan, Wilcox, Mark H.
Publicado 2017

The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England

por Duerden, Brian, Fry, Carole, Johnson, Alan P., Wilcox, Mark H.
Publicado 2015

Antibiotic strategies in the era of multidrug resistance

por Karam, George, Chastre, Jean, Wilcox, Mark H., Vincent, Jean-Louis
Publicado 2016

The Efficacy and Safety of Fecal Microbiota Transplant for Recurrent Clostridiumdifficile Infection: Current Understanding and Gap Analysis

por Wilcox, Mark H, McGovern, Barbara H, Hecht, Gail A
Publicado 2020

Lower Urinary Tract Infections: Management, Outcomes and Risk Factors for Antibiotic Re-prescription in Primary Care

por Pujades-Rodriguez, Mar, West, Robert M., Wilcox, Mark H., Sandoe, Jonathan
Publicado 2019

Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections

por Pai, Manjunath P, Wilcox, Mark H, Chitra, Surya, McGovern, Paul C
Publicado 2021

K-mer based prediction of Clostridioides difficile relatedness and ribotypes

por Moore, Matthew Phillip, Wilcox, Mark H., Walker, A. Sarah, Eyre, David W.
Publicado 2022

Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production

por Chilton, Caroline H., Crowther, Grace S., Ashwin, Helen, Longshaw, Chris M., Wilcox, Mark H.
Publicado 2016

Role of cephalosporins in the era of Clostridium difficile infection

por Wilcox, Mark H., Chalmers, James D., Nord, Carl E., Freeman, Jane, Bouza, Emilio
Publicado 2017

Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence

por Garey, Kevin W., Rose, Warren, Gunter, Kyle, Serio, Alisa W., Wilcox, Mark H.
Publicado 2022

Evaluating the impact of testing strategies for the detection of nosocomial COVID-19 in English hospitals through data-driven modeling

por Evans, Stephanie, Stimson, James, Pople, Diane, Wilcox, Mark H., Hope, Russell, Robotham, Julie V.
Publicado 2023